(II-1A.4d) 71-year-old patient with patent ductus arteriosus P. Prochownik, A. Sarnecka MD, G. Kopeć MD, PhD, M. Komar MD, PhD, Prof. P. Podolec MD, PhD

 

BRIEF COMMENTS

EXPERT: Krzysztof Szymoński, MD
Affiliation: Department of Cardiovascular Surgery and Transplantology, John Paul II Hospital, Krakow, Poland
COMMENT
Due to current ESC guidelines the patient qualifies for PDA closure. Tricuspid valvuloplasty may also be considered.

EXPERT: Grzegorz Kopeć, MD, PhD
Affiliation: Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow
COMMENT
Because there is no possibility of pulmonary hypertension targeted treatment the patient qualifies for PDA closure. Coexisting tricuspid regurgitation seems to be secondary to pulmonary hypertension.

EXPERT: Lidia Tomkiewicz-Pająk, MD, PhD
Affiliation: Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow
COMMENT
Regarding coexisting calcifications in the area of connection of PDA and aorta, percutaneus closure of PDA seems to be preferable.

CONCLUSIONS

1. Due to current ESC guidelines there are indications for PDA closure in this patient.
2. In presented clinical situation there is no possibility of pulmonary arterial hypertension targeted treatment.
3. Percutaneous closure of PDA is a method of choice.

 

 


“Development of the European Network in Orphan Cardiovascular Diseases”
„Rozszerzenie Europejskiej Sieci Współpracy ds. Sierocych Chorób Kardiologicznych”

This entry was posted in 1. Pulmonary hypertension, 4. PAH associated with, Case presentations, II. Rare diseases of pulmonary circulation. Bookmark the permalink.

Comments are closed.